Indicated for insomnia to alleviate difficulty falling asleep and manage sleep maintenance.
Mechanism of Action
The active substance interacts with the GABA-receptor complex at binding domains located near or allosterically coupled to benzodiazepine receptors, enhancing the inhibitory effects of GABA to induce and maintain sleep.
Route of Administration
Oral
Onset Time
15–30 minutes
Duration
7–8 hours
Contraindications
History of complex sleep behaviors, Severe hepatic impairment, Hypersensitivity to eszopiclone
Severe Adverse Events
Complex sleep behaviors, Anaphylaxis, Severe memory impairment — requires immediate medical attention
Information related to Hypnite is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
